-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
AEON Biopharma, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate for 2022.
- AEON Biopharma, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2023 was $0.000.
Income Tax Expense (Benefit), Annual (USD)